The largest database of trusted experimental protocols

Mmff94

Manufactured by Merck Group
Sourced in United States, Hungary, Canada, Germany

MMFF94 is a molecular mechanics force field developed by Merck Group. It is designed to accurately model the potential energy of molecular structures and their conformations. The MMFF94 force field provides a comprehensive set of parameters for the calculation of molecular energies, geometries, and other properties. It is widely used in the fields of computational chemistry and molecular modeling.

Automatically generated - may contain errors

66 protocols using mmff94

1

Drug Repositioning for SARS-CoV-2 Helicase

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug ReposER tool, a web server that uses a modified version of the SPRITE search engine to identify similar amino acid arrangements to known drug binding interfaces for potential drug repositioning, was used to predict/identify drugs that could interact with the SARS-CoV-2 helicase based on the presence of amino acid arrangements matching binding sites of drugs in previously annotated protein structures28 (link). The tool predicts the binding of drugs with query protein based on RMSD. We used RMSD of 3.0 Å or less as the threshold, and structures of drugs exhibiting RMSD 3.0 Å and under were retrieved from PubChem Database in 3D SDF format. The 3D geometrical structures of drugs were then minimized by the Merck Molecular Force Field 94 (MMFF94S) force field using SZYBKI software29 ,30 (link). Before docking analysis, SDF structures were converted to PDBQT format using the OpenBabel tool, and polar hydrogens were added to the drug structures during conversion31 (link).
+ Open protocol
+ Expand
2

Pharmacophore Model of SARS-CoV-2 Mpro Inhibitor

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 3D structure-based pharmacophore model was built from the crystalline protein–ligand complex of the main protease of SARS-CoV-2 and the inhibitor N3 (7BQY), obtained from the PDB protein database (https://www.rcsb.org/, accessed on 8 June 2020), with a resolution of 1.7 Å [28 (link)]. The binding site of the crystalline complex was identified, and its minimization energy was calculated using Merck Molecular Force Field 94 (MMFF94s) considering a solvated environment. Subsequently, the pharmacophore model was created using the pharmacophore generation tool of the LigandScout 4.4 Advanced software. The pharmacophore model provided the 3D coordinates of the minimal molecular interactions of the co-crystallized inhibitor (N3) binding mode at the Mpro recognition site of the virus.
+ Open protocol
+ Expand
3

Conformational Analysis and ECD Calculations

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Merck molecular force field (MMFF94S) was used to conformational searches of compounds 12 and 67 during theoretical ECD calculations. All conformers were optimized twice by the basis set at the B3LYP/6-31G (d) and B3LYP/6-311+G (d) levels using the Gaussian 09 (Gaussian Inc., Wallingford, CT, USA) [39 ]. The ECD spectrum was calculated by the time-dependent density functional theory (TD-DFT) method at B3LYP/6-311++G (2d, p) level and simulated by Boltzmann distributions in SpecDis 1.62 (University of Würzburg, Würzburg, Germany) [40 (link)].
+ Open protocol
+ Expand
4

Molecular Modeling of Thiourea Derivatives

Check if the same lab product or an alternative is used in the 5 most similar protocols
The molecular model of the new thiourea derivatives was done using MOE software suite 10.2008. Following geometry optimization, a systematic conformational search was carried out to RMS gradient of 0.05 Å with energy minimization of the resultant conformations employing the ConfSearch module implemented in MOE. All molecular mechanics computations were performed with the Merck Force Field (MMFF94s). The crystallographic structure of M. tuberculosis enoyl reductase InhA in complex with N-{1-[(2-chloro-6-fluorophenyl)methyl]-1H-pyrazol-3-yl]-5-[(1S)-1-(3-methyl-1H-pyrazol-1-yl)ethyl]-1,3,4-thiadiazol-2-amine (GSK 625) was obtained from the Protein Data Bank (PDB ID: 5JFO). Water molecules were ignored and hydrogen atoms were added to the enzyme and partial charges were calculated. Validation followed by docking of the compounds into the active site were carried out, after removing the co-crystallized ligand. The target protein was kept rigid, while the ligands adopt 50 separate docking simulations using default parameters. The conformations were chosen based on their S score, and appropriate fitting with the relevant amino acids in the binding pocket.
+ Open protocol
+ Expand
5

CXCR4 Agonist Library Generation and Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
As per proposed concept, the primary requirement is molecules already in the market, well profiled, and may be used for patient treatments. Therefore, we collected approved and well-known agonists of the proposed receptor CXCR4 along with the IC50 values from the literature. Molecules were collected and compiled, and three-dimensional (3D) structures were generated using openbabel (OB)[56 (link)], and energy optimization (obminimize, an OB module) was used with the steepest descent method for 500 steps using the Merck molecular force field, MMFF94s[57 (link)]. The molecules were stored in.mol2 format, and the overall dataset resulted in 175 molecules (Additional file 6: Table S1), which were referred to as the training dataset. The processed molecules were labeled as inhibitors (1 or positive) if IC50 < 0.05 µM, and the remaining were non-inhibitors (0 or negative), resulting in a dataset consisting of 81 inhibitors and 94 non-inhibitors (Additional file 6: Table S1). We prepared an independent evaluation dataset, retrieved from a directory of useful decoys-enhanced (DUD-E)[58 (link)], comprises 56 molecules, specifically for the CXCR4 receptor, classified as per their IC50 value out of which 43 were inhibitors (1/active) and 13 non-inhibitors (0/decoy). The evaluation dataset was prepared as per the training dataset (Table 1).
+ Open protocol
+ Expand
6

Structural Optimization and Docking of SOX Derivatives

Check if the same lab product or an alternative is used in the 5 most similar protocols
The two-dimensional structures of synthesized SOX derivatives were drawn with the help of ChemDraw Professional v15.1 and subjected to prepare a three-dimensional structure with the help of Chem3D v15.1. The structural modification, geometrical correction, and optimization were performed with the help of Merck Molecular Force Field (MMFF94). Protoss is an online tool that automatically predicts hydrogens for the interaction between protein-ligand complexes (https://proteins.plus/), accessed on 5 February 2022. The substituted SOXs were subjected to a single-step minimization by the steepest descent method for 500 steps and an RMS gradient of 0.01 [85 (link)]. To perform docking analysis, the eutectic state of protonation of the ligands was found at pH 7.4.
+ Open protocol
+ Expand
7

In Silico Analysis of Amarisolide A

Check if the same lab product or an alternative is used in the 5 most similar protocols
An in silico analysis was performed to assess whether there is a role of serotonin 5-HT1A inhibitory receptors in producing the antihyperalgesic and antiallodynic effects of amarisolide A. The crystal structure of the compound amarisolide A was obtained from the PubChem database. The structure was protonated using the Avogadro software V1.2.0 (Avogadro Chemistry, Pittsburgh, PA, USA) at pH 7.4, and the minimum energy spatial configuration was subsequently determined using the Merck Molecular Force Field (MMFF94, Merck Research Laboratories, Boston, MA, USA). The protein structure of serotonin 5-HT1A receptor (7E2X) was obtained from the Protein Data Bank (PDB, https://www.rcsb.org/ (accessed on 14 November 2022)), selecting a resolution of less than 3 Å. Then, the docking was performed with the CB-Dock tool [47 (link)]. The results of the CB-Dock tool software V2.0 (Structural Bioinformatics Research group, Chengdu, China) were contrasted with UCSF Chimera 1.16 (Resource for Biocomputing, Visualization, and Informatics University of California, San Francisco, CA, USA) to protein preparation and Autodock vina 1.1.2 (Oleg Trott, La Jolla, CA, USA).
+ Open protocol
+ Expand
8

Novel Cav2.2 Inhibitors from Conotoxin Mimetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Initially, 30 inhibitors were retrieved against Cav2.2 through extensive literature survey (Table S1). These inhibitors were non-peptide mimetics of ω-conotoxins (MVIIA, CVID and GVIA) isolated from cone snail. From these 30 inhibitors, 7 compounds were filtered out based on their pore binding positions (Table S2). In C1, three important amino acids mimetics (R10, L11 and Y13) of ω-conotoxin MVIIA were attached to dendritic scaffold [41] (link). In C2-4 benzothiazole scaffold [48] (link), [38] (link) and in C5 and C6 contained anthranilamide scaffold that projected the side chain mimetics of the key residues (K2, Y13 and R17) in ω-conotoxin GVIA [43] , [48] (link). C7 shared a similar pattern to that of C6, except bearing an anthranilamide scaffold that was modified by replacing phenoxyaniline substituent with a diphenylmethylpiperazine moiety [40] (link). 2D structures of these inhibitors were drawn by ChemDraw Pro 12.0 [49] and converted into 3D coordinates that were further energy minimized using Avogadro® [50] tool through Merck Molecular Force Field (MMFF94) and steepest descent algorithm [51] .
+ Open protocol
+ Expand
9

Phytochemicals and FDA Drugs Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 263 phytochemicals and 75 FDA approved antiviral drugs were retrieved from the database of Indian Plants, Phytochemistry And Therapeutics (IMPPAT) (Mohanraj et al., 2018 (link)) and DrugBank database (Wishart et al., 2008 (link)) respectively. The three-dimensional structure of the molecules was downloaded in SDF format and the molecules whose only two-dimensional structures were available, were converted into the three-dimensional form using OpenBabel software version 2.4.1 (O’Boyle et al., 2011 (link)) and optimized using the Merck molecular force field (MMFF94) (Halgren, 1996 (link)).
+ Open protocol
+ Expand
10

Molecular Energy Landscape Approximation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Merck Molecular Force Field, MMFF94 [38 (link)] was used to evaluate the energy of a given molecule as implemented in Open Babel 2.4.1 [33 (link)]. This is an approximation of the molecule’s actual energy landscape; ideally, we would use quantum chemical methods to compute the molecule’s energy as accurately as possible [39 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!